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Dietary epicatechin improves survival and delays
skeletal muscle degeneration in aged mice
Hongwei Si,*,1 Xiaoyong Wang,* Longyun Zhang,* Laurence D. Parnell,† Bulbul Ahmed,* Tanya LeRoith,‡
Twum-Ampofo Ansah,§ Lijuan Zhang,* Jianwei Li,{ José M. Ordovás,k,#,** Hongzong Si,†† Dongmin Liu,‡‡,2
and Chao-Qiang Lai†,3
*Department of Human Sciences and {Department of Agriculture and Environmental Sciences, Tennessee State University, Nashville,
Tennessee, USA; †United States Department of Agriculture (USDA) Agricultural Research Service and kNutrition and Genomics Laboratory,
Jean Mayer USDA Human Nutrition Research Center on Aging at Tufts University, Boston, Massachusetts, USA; ‡Department of Biomedical
Sciences and Pathobiology, Virginia–Maryland Regional College of Veterinary Medicine, Blacksburg, Virginia, USA; §Department of
Neuroscience and Pharmacology, Meharry Medical College, Nashville, Tennessee, USA; #Research Institute on Food and Health Sciences,
Madrid Institute of Advanced Studies (IMDEA), Campus of Universal Excellence (CEI), Autonomous University of Madrid (UAM), Madrid,
Spain; **Superior Council of Scientific Investigations (CSIC), Madrid, Spain; ††Institute of Computational Science and Engineering, Qingdao
University, Qingdao, China; and ‡‡Department of Human Nutrition, Foods and Exercise, Virginia Tech, Blacksburg, Virginia, USA
ABSTRACT: We recently reported that epicatechin, a bioactive compound that occurs naturally in various common
foods, promoted general health and survival of obese diabetic mice. It remains to be determined whether epi-
catechin extends health span and delays the process of aging. In the present study, epicatechin or its analogue
epigallocatechin gallate (EGCG) (0.25%w/v indrinkingwater)was administered to 20-mo-oldmaleC57BLmice fed
a standard chow. The goal was to determine the antiaging effect. The results showed that supplementation with
epicatechin for 37 wk strikingly increased the survival rate from 39 to 69%, whereas EGCG had no significant effect.
Consistently, epicatechin improved physical activity, delayed degeneration of skeletalmuscle (quadriceps), and shifted
the profiles of the serummetabolites and skeletalmuscle generalmRNAexpressions in agingmice toward the profiles
observed in youngmice. In particular, we found that dietary epicatechin significantly reversed age-alteredmRNA and
protein expressions of extracellularmatrix and peroxisome proliferator–activated receptor pathways in skeletalmuscle,
and reversed the age-induced declines of the nicotinate and nicotinamide pathway both in serum and skeletal muscle.
The present study provides evidence that epicatechin supplementation can exert an antiaging effect, including an
increase in survival, an attenuation of the aging-related deterioration of skeletal muscles, and a protection against the
aging-relateddecline innicotinate andnicotinamidemetabolism.—Si,H.,Wang,X., Zhang, L., Parnell, L.D.,Ahmed,B.,
LeRoith, T., Ansah,T.-A., Zhang, L., Li, J., Ordovás, J.M., Si,H., Liu,D., Lai, C.-Q.Dietary epicatechin improves survival
and delays skeletal muscle degeneration in agedmice. FASEB J. 33, 965–977 (2019). www.fasebj.org
KEY WORDS: antiaging • extracellular matrix pathway • nicotinamide pathway • PPAR pathway • lifespan
Aging is a progressive, systematic dysfunction of almost
all organs and tissues, aswell as an escalated vulnerability
to environmental challenges. The increased dysfunction
and vulnerability not only result in reduced physical ac-
tivity and quality of life but also compound the risks of a
number of degenerative diseases such as cardiovascular
disease, type 2 diabetes, cancer, Alzheimer’s disease, and
sarcopenia, which account for .70% of deaths among
Americans aged $65 yr (1). Therefore, either delaying the
aging process or preventing development of these chronic
ABBREVIATIONS: BW, body weight; CR, calorie restriction; EC, epicatechin-treated; ECM, extracellular matrix; EGCG, epigallocatechin gallate; FPKM,
fragments per kilobase of transcript per 106 mapped reads; H&E, hematoxylin and eosin; PPAR, peroxisome proliferator–activated receptor; NAD, nicotinate
and nicotinamide; OC, old control; PAS, periodic acid–Schiff; SkM, skeletal muscle; UPLC-MS/MS, ultra-high-performance liquid
chromatography–tandem mass spectroscopy; USDA, U.S. Department of Agriculture; YC, young control
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diseases is an essential strategy to promote healthy aging. It
is well established that calorie restriction (CR) delays age-
associated organ disorders and increases life span in awide
range of species, including humans (2), suggesting that tar-
geting nutrient-sensing and energy metabolism pathways
maybe an effective approach todelay the agingprocess and
age-related diseases. However, long-term energy restriction
might not be a practical strategy for the general population.
Accumulatingevidencesupports that food-derivedsmall
molecules (also called phytochemicals), albeit not consid-
eredessentialnutrients,have thepotential toextendlife span
inmodel organisms and to reduce risk of chronic diseases in
humans (3, 4). Resveratrol, a well-known phytochemical,
has been shown to improve health and extend life span by
mimicking CR in obese mice induced by feeding of a high-
fatdiet (5)butnot inmice fedastandardchowdiet (6).These
findings indicate that the resveratrol effect is mediated by
favorable modulation of the increased vulnerability to the
physiologic and metabolic alterations of major organs and
tissues induced by feeding of a high-fat diet or obesity but
not viadirectly targetingantiagingmoleculeswithinhealthy
aging processes. In addition, it was found that most
potentially health-promoting phytochemicals such as
resveratrol, green tea extract, curcumin, oxaloacetic acid,
and medium-chain triglyceride oil (chain length of 6–10
carbons) all have failed to extend life span in standard
diet–fed lean mice in the National Institute on Aging
Interventions Testing Program (7). Therefore, identifying
safe, bioactive compoundswith robust antiaging effects in
rodents and humans remains an elusive goal.
Cocoa intake was speculated to be the key factor that
contributed to the longer andhealthy life spanof inhabitants
of San Blas Island comparedwith those living onmainland
Panama (8). Many studies have shown that epicatechin, a
flavanol, is primarily responsible for the beneficial effects of
dietary cocoa, including promoting vascular function (9)
and skeletal muscle (SkM) health and combating oxidative
stress (10, 11). In our screening of antidiabetic compounds,
we unexpectedly found that epicatechin promoted health
andsurvivalofobesediabetic (ob/ob)mice (12).Notably, this
effect of epicatechin was not the consequence of improved
circulating glucose and insulin levels. We further showed
that dietary provision of epicatechin extended life span in
Drosophila. Theseobservations suggest that epicatechinmay
be a novel antiaging agent. Therefore, in the present study,
we investigated the effects of epicatechin supplementation
on the survival rate and physical performance in agedmice
fed a standard diet. In addition, transcriptome and metab-
olomic analyseswere conducted to explore themechanisms
underlying the effects of epicatechin on survival and aging.
MATERIALS AND METHODS
Animals
Male C57BL/6 mice (20 or 9-mo old) were purchased from the
National Institute on Aging (Bethesda, MD, USA). Mice were
housed in an environmentally controlled (23 6 2°C; 12-h light/
dark cycle) animal facility and were provided free access to
Teklad global rodent chow diet (Harlen, Indianapolis, IN, USA).
Twenty-month-old mice were randomly divided into 3 groups
(n = 33/group) and given either 0% [old control (OC)] or 0.25%
(w/v) of epicatechin (MilliporeSigma, Burlington, MA, USA)
or epigallocatechin gallate (EGCG; MilliporeSigma, Burlington,
MA,USA) in drinkingwater for 37wk (12micewere euthanized
to collect tissues)or44wk (rest of themicewere treated for7more
wk). The 9-mo-old mice were used as young control (YC) to
collect tissues only. This dosage (0.25% w/v) of epicatechin or
EGCG [~150mg/kgbodyweight (BW)]was calculated based on
previous experiments using cocoa products in humans (100–
400 mg/kg BW) and the mean concentration of flavanols in co-
coa. To ensure stability of the epicatechin, stock epicatechin was
stored at280°C, and itswater solutionwaskept from light. Fresh
epicatechin solution was made and provided to the mice every
otherday.BWandfoodandwater intakesweremonitoredweekly.
Fasting (overnight) glucose was measured every 2 months, and a
glucose tolerance test was conducted at month 26. The general
clinical condition andmortality of the mice were monitored daily.
The criteria for euthanasia were independently assessed by a
veterinarian according to the guidelines of the Association for As-
sessment and Accreditation of Laboratory Animal Care In-
ternational. Mice with BW,30% of original BWwere euthanized
by inhalation of CO2. All natural deaths or euthanized mice
were counted as death to plot the survival curves. Survival curves
were plotted by using the Kaplan-Meier method and included all
available animals at each time point (13). After 37 or 44 wk, the
remaining mice were euthanized by inhalation of CO2, and blood
and tissue samples including SkM (right quadriceps muscle) were
immediately collected and stored at280°C or in 10% formalin for
biochemical and physiologic analysis. The animal protocol was
approved by the Institutional Animal Care and Use Committee at
Tennessee State University and was reported in accordance with
theAnimal Research: Reporting of InVivoExperiments guidelines.
Physical activity measurement and
pathologic analysis
Physical activity (12mice/group)was evaluated byperforming an
open field test using a computer-controlled activity monitoring
system (Med Associates, St. Albans, VT, USA), as we previously
reported (14). Briefly, the individual mouse was placed in the
chamber for 15 min without interruption, and parame-
ters (including distance traveled, ambulatory count, stereotypic
count, time resting, vertical count, jump count, and average ve-
locity) were recorded simultaneously. For pathologic or EGCG
analysis, formalin-fixed SkM (right quadriceps muscle) samples
were sectioned and stained with hematoxylin and eosin (H&E)
and periodic acid–Schiff (PAS). Pathologic alterations in SkM, in-
cluding extensive fiber vacuolization and degeneration, average
minimum Feret diameter and central nucleation in H&E, and glyco-
genaccumulation(the indicatorofdegenerativeprocess) inPAS,were
blindlyevaluatedaspreviouslydescribed (12). Inbrief, thepathologic
alterations of quadriceps muscle were graded based on the average
minimum Feret diameter (average, mm), presence of central nucle-
ation and atrophic fibers (%) in H&E, and the accumulation of gly-
cogen (%) in PAS. Three sections from each mouse were examined,
and ten 2.37 mm2 fields of each section were evaluated.
Metabolomics and metabolite analyses
Global biochemical profileswere determined by using the serum
(12 mice/group) from each mouse. Metabolomic profiling anal-
ysis was performed by Metabolon (Durham, NC, USA) using
ultra-high-performance liquid chromatography–tandem mass
spectroscopy (UPLC-MS/MS) platforms, as previously de-
scribed (15). In brief, sample (100 ml serum) preparation was
conducted by using a proprietary series of organic and aqueous
extractions to remove the protein fraction while allowing
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maximumrecoveryof smallmolecules. The resultant extractwas
divided into 4 fractions: one for analysis by UPLC-MS/MS
(positivemode), one forUPLC-MS/MS (negativemode), one for
GC-MS, and one for backup. The sample extract was dried and
then reconstituted in acidic or basic liquid chromatography–
compatible solvents, each of which contained $8 injection
standards at fixed concentrations to ensure injection and chro-
matographic consistency. The data were extracted, with peaks
and compounds identified by using the local area network
backbone anddatabase server runningOracle 10.2.0.1 Enterprise
Edition (Oracle, Redwood City, CA, USA).
Principal component analysis
Principal components were computed by determining the coef-
ficients of the metabolites or mRNA expression that maximize
the variance of the linear combination. The total variance was
definedas the sumof thevariancesof thepredictedvaluesof each
component (the variance is the SD2), and for each component, the
proportion of the total variance was computed.
Random forest
The mean decrease in accuracy was determined by randomly per-
muting a variable, running the observed values through the trees,
and then reassessing the prediction accuracy. The result was pro-
vided as an importance rank ordering of the top 30 biochemicals.
Metabolic pathway analysis
All detectedmetabolites (n = 671) were organized intometabolic
pathways based on the annotation database of Metabolon. Only
pathways that contained$3 detectedmetaboliteswere included
in the pathway analysis. There are a total of 58 pathways. Sig-
nificantly changed metabolites between groups were selected to
determine enrichment of metabolic pathways, which was de-
termined by calculating the z-score test (16). Significance values
were adjusted for multiple testing by using the Bonferroni test
(i.e., P# 0.05/58 = 0.00086).
mRNA sequencing and pathway analysis
Total RNA fromSkM (right quadriceps)was extracted by using the
RNeasy Fibrous Tissue Mini Kit (Qiagen, Valencia, CA, USA), and
RNA quality was assessed by using an Agilent 2100 Bioanalyzer
(Agilent Technologies, Santa Clara, CA, USA). A total of 3mg RNA
per sample was used as input material for the sequencing library
preparations following themanufacturer’sprotocol. The sequencing
was performed by using an Illumina External HiSeq2500 High
Output SE 50 (Illumina, San Diego, CA, USA). Transcriptome as-
sembly and differential expression analyses were conducted with
theCufflinks package and default parameters (http://cole-trapnell-lab.
github.io/cufflinks/cuffdiff). mRNA expression was expressed as
fragments per kilobase of transcript per 106 mapped reads
(FPKM). Comparisons of gene expression between groupswere
performed by using the cuffdiff function within Cufflinks
package. The FPKM of 8 samples of each groupwas used for 1-
or 2-wayANOVA.Geneswith anadjustedvalue ofP,0.05 (i.e.,
q value with false discovery rate correction for multiple testing)
were assigned as significantly differentially expressed.
We selected 10,930 genes (the average FPKM value of
each gene in the young control group is .1.00) in all 3
groups to conduct a principal components analysis as pre-
viously described (17). Significantly changed genes be-
tween groups were applied to the Gene Set Enrichment
Analysis (http://software.broadinstitute.org/gsea/msigdb/annotate.jsp)
using the canonical pathways to identify enriched pathways.
Pathways with values of q , 0.5 were listed as significantly
enriched pathways.
Protein detection and measurement
To verify whether the genes with significantly differential ex-
pression result in changes in protein levels, Western blots were
performed to measure relevant protein levels in SkM (right
quadriceps), as we have previously described (12). Membrane
fractionswereprobedwith aprimaryantibodyagainst total actin
or peroxisome proliferator–activated receptor (PPAR) g (Cell
Signaling Technology, Danvers, MA, USA). Protein bands were
digitally imaged for densitometric quantitation with the ImageJ
software program (National Institutes of Health, Bethesda, MD,
USA). The expression of the relevant protein was normalized to
the glyceraldehyde-3-phosphate dehydrogenase level from the
same sample.
Statistical analyses
Survival curveswereplotted byusing theKaplan-Meiermethod,
including all available mice at each time point, and the log-rank
test was applied to compare the survival distributions of the
control and epicatechin-treated (EC) groups. The results from
pathologic analysis of the SkM were analyzed by using a
Kruskal-Wallis test. All other data were analyzed with 1-way
ANOVA, and significant differences between treatment groups
were further analyzedbyusing theTukey test. Values ofP, 0.05
were considered statistically significant.
RESULTS
Epicatechin supplementation increases
survival of aged mice
To determine the effects of epicatechin on life span, 20 mo
old C57BL/6 male mice fed the standard diet were pro-
vided with epicatechin or EGCG dissolved in drinking
water (0.25% w/v) for 37–44 wk. We observed that old
mice given epicatechin intake had a strikingly higher
survival rate (69%) comparedwith theOCmice (39%)after
37wkof treatment (Fig. 1A). In total, 44%ofmicewere still
alive in the EC group after 7 additional wk of epicatechin
treatment. However, EGCG supplementation had no sig-
nificant antiaging effect (P = 0.56) as the survival curves
of EGCG and OC were almost overlapped before wk 29
after removing the first 5 dead mice because of EGCG
supplementation–induced dehydration (Supplemental
Fig. 1). Therefore, this dehydrationmaymask, enhance, or
otherwise alter the EGCG antiaging effects. Epicatechin-
supplemented mice slightly gained BW (Fig. 1B) and had
reduced food and water intakes compared with the OC
group (Fig. 1C, D). These patterns of the average BW and
food and drink intake are in line with the data of these
measurements over the entire experimental period (Fig.
1E). Interestingly, the amount of visceral fat was signifi-
cantly higher in EC mice compared with the OC group
(Supplemental Table 1). However, epicatechin did not
significantly alter glucose tolerance (Fig. 1F) and fasting
blood glucose (Fig. 1G) in aged mice, in agreement with
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our previous report (12); these findings suggest that the
epicaechin life span–extendingeffect inagedmice isnotvia
regulation of glucose metabolism.
Epicatechin increases physical activity levels
and delays SkM degeneration
Because adecline inphysical activity due todysfunctionof
SkM is associated with aging, we measured physical ac-
tivity of the mice throughout the experiment by using a
computer-controlled monitoring system (14). Epicatechin
intake improved physical activity metrics, including
traveling distance (a measurement of gross locomotor ac-
tivity) (Fig. 2A) and the time, counts, and episodes of
ambulatory (exploratory behavior) in agedC57BL/6mice
(Fig. 2B–D).
Age-related dysfunction of SkM is associated with a
reduction of protein synthesis and an increase in pro-
tein degradation (18). To determine whether epi-
catechin delays SkMdegradation, a pathologic analysis
of SkM was conducted. As shown in Fig. 2E, OC mice
displayed a dramatic increase in SkM degeneration
Figure 1. Effects of dietary sup-
plementation of epicatechin on
survival rate in aged mice fed a
standard diet. Twenty-month-old
male C57BL/6 mice were treated
with EC (0.25% w/v in drinking
water) or control (OC) for 37 or
44 wk (n = 33/group). A) Epi-
catechin intake significantly in-
creased survival rate of mice.
B–D) Epicatechin intake en-
hanced BW (B) while decreasing
food and drink intake (C, D)
during the experimental period.
E) The average BW, food intake,
and drink intake of the entire
experimental period. F, G) Epi-
catechin intake did not signifi-
cantly affect the results of the
glucose tolerance test (F) or
fasting plasma glucose levels
(G). *P , 0.05 EC vs. OC (n =
12–33).
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characterized by extensive fiber vacuolization and de-
generation (central nucleation and degenerated fibers)
and accumulation of glycogen in some atrophic fibers
compared with the YC mice. However, epicatechin in-
take significantly ameliorated these age-associated
degenerative changes of SkM in aged mice, indicating




with the NAD metabolic pathway
A metabolomic analysis of serum was conducted to de-
termine the difference inmetabolic profiles of YC,OC, and
EC mice. A total of 671 metabolites were detected in the
serum,with levels of 390 being significantly different (139
reduced, 251 increased) between young and aged mice.
Among these, 47 metabolite levels were altered by EC
treatment in aged mice. Principal component analysis
based on all 671 metabolites revealed perfect separation
between YC and OC mice, and epicatechin supplementa-
tion significantly shifted themetabolic profiles of oldmice
toward those in young mice (Fig. 3A). Using the detected
671 metabolites, a further random forest analysis was
performed to identify 36 metabolites that distinguish the
3 groups (YC, OC, and EC). This method resulted in a
predicted accuracy of 78% between groups using these
36 metabolites (Fig. 3B). The top 2 categories of me-
tabolites identified according to the random forest
analysis were lipids and xenobiotics, indicating that
these metabolites could serve as biomarkers of the epi-
catechin antiaging effects. The 6 metabolites that were
most significantly different between the OC and EC
groups are 3-hydroxyhippurate, 3-hydroxycinnamate
sulfate, nicotinate ribonucleoside, nicotinamide, N1-
methyl-2-pyridone-5-carboxamide, and N1-methyl-4-
pyridone-3-carboxamide (Fig. 3C–H).
NAD+ is an essential electron transporter in mito-
chondrial respiration and oxidative phosphorylation (19),
and NAD metabolism is important in aging processes.
Interestingly, aging reduced serum levels of 2major NAD
metabolism-related molecules—nicotinate ribonucleoside
(Fig. 3E) and nicotinamide (Fig. 3F)—but these reductions
were reversed by epicatechin. Furthermore, ourmetabolic
pathway analysis identified that the NAD metabolic
pathway (P = 0.00081) is one of the top 5 pathwayswhose
metabolite components are significantly different between
OC and EC mice after correction of multiple testing
(Table 1). These findings support an important role for
Figure 2. Effects of dietary
epicatechin on physical activity
and SkM pathology. Twenty-
month-old male C57BL/6 mice
were treated with EC (0.25%
in drinking water) or control
(OC) for 9 mo (37 wk). A–D)
Physical activity metrics [dis-
tance traveled (A), ambulatory
episodes (B), ambulatory time
(C), ambulatory count (D)]
were tested by using a com-
puter-controlled activity moni-
toring system at 20, 22, 24, and
28 mo of age (n = 12/group).
E) SkM tissue (quadriceps) spec-
imens were pathologically an-
alyzed after H&E and PAS
staining. Original magnifica-
tion, 3400: Arrow indicates
central nucleation; arrowhead
indicates degenerating fiber.
#P , 0.05 OC vs. YC; *P ,
0.05 EC vs. OC. n = 12.
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NAD in the antiaging effect of epicatechin, given that
NAD+ levels decline with age (20).
Epicatechin reverses age-related changes
in genes associated with the extracellular
matrix and PPAR pathways
Because epicatechin intake improved SkM function and
curtailed SkM pathologic degeneration, we then per-
formed transcriptome analysis by conducting whole ge-
nome RNA sequencing of the SkM tissue. We selected
10,930 genes (whereby the average FPKM value of each
gene in the YC group was .1.00) to conduct a principal
components analysis to characterize the differences be-
tween the 3 groups. Dietary supplementation of epi-
catechin significantly shifted the transcriptome profiles of
old mice toward those in youngmice (Fig. 4A), indicating
that epicatechin intake reversed age-associated changes in
SkMgene expression.We found that 791 genes inOCmice
displayed significant expression changes (599 decreased,
192 increased) compared with YC mice, and 222 genes in
EC mice were significantly different compared with OC
mice. Further analysis revealed that mRNA levels of 162
genes were reduced in OC mice compared with YC mice
but were reversed by epicatechin intake. Among these 2
sets of differential expression genes (791 genes of YC vs.
OC, and 222 genes of EC vs. OC), we observed that 92
transcripts were common. Of these 92 genes, expression
levels of 87 were significantly reduced in OC mice com-
pared with YC mice; they were significantly reversed in
the EC group, however, underscoring the antiaging effect
of epicatechin in SkM.
The differentially expressed genes were then subjected
toGene Set EnrichmentAnalysiswith canonical pathways
Figure 3. Dietary epicatechin reversed age-related metabolomic changes associated with NAD pathway in aged mice. Principal
component analysis revealed perfect separation between YC and OC, and EC intake significantly shifted back to YC (A). Random
forest analysis resulted in a predicted accuracy of 78% between groups (B), and levels of 6 metabolites were significantly changed
by EC compared with the OC group (C–H). #P , 0.05 EC vs. YC; *P , 0.05 EC vs. OC (n = 12/group).
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to identify the pathways associated with epicatechin an-
tiaging effects. By applying those genes with significant
changes in their expression levels betweenYCandOC,OC
andEC, or sharedgenes between2 sets (YC vs.OCandOC
vs. EC), and correcting for multiple testing, a set of path-
ways were identified that were modulated by epicatechin
treatment (Table 2 and Supplemental Table S2) and by
aging (Table 2 and Supplemental Table S3). In particular,
we found that extracellularmatrix (ECM),PPAR-signaling
pathway, and metabolism of lipid and lipoprotein are
the top 4 pathways in all 3 comparisons (Table 2 and
Supplemental Tables S2–4), and these pathways play
critical roles in SkM function (21, 22). Our subsequent
analysis indicated thatmRNAexpression ofmost genes in
the ECM (24 genes) (Fig. 4B),PPAR (8 genes) (Fig. 4C), and
lipid and lipoprotein (17 genes) (Fig. 4D) pathways were
reduced in old mice compared with those in young mice
but were significantly reversed by epicatechin intake.
Particularly, 5 gene transcripts in the NAD pathway were
significantly reduced in old mice relative to the young
mice but were up-regulated by epicatechin to the levels
comparable to those of the young mice (Fig. 4E), which





(P # 0.05)b Z score P c
Benzoate metabolism 16 5 4.145 3.40E205
Glycine, serine, and threonine metabolism 9 3 3.348 8.14E204
Pyrimidine metabolism, uracil containing 9 3 3.348 8.14E204
NAD metabolism 9 3 3.348 8.14E204
Glycolysis, gluconeogenesis, and pyruvate
metabolism
8 2 2.18 2.93E202
Pyrimidine metabolism, cytidine containing 9 2 1.97 4.88E202
aDetected metabolites assigned to the respective pathway. bMetabolites that are significantly different
between EC and OC mice. cUnderlined values are significant after correction for multiple testing by using
the Bonferroni test (i.e., P # 0.00086).
Figure 4. Dietary epicatechin
reversed age-related changes
in gene expressions and path-
ways of quadriceps muscles in
aged mice. The mRNA sequenc-
ing results show that a clear
separation between YC and OC,
and epicatechin intake signifi-
cantly shifted back to YC (A)
according to the principal com-
ponent analysis. Nearly all genes
of 4 pathways—matrisome [25
genes (B)], PPAR [8 genes (C)],
lipids and lipoprotein [17 genes
(D)], and NAD [5 genes (E)]—
showed decreased expression
during aging, but expression of
all genes were significantly re-
versed by epicatechin intake.
#P , 0.05 EC vs. YC; *P , 0.05
EC vs. OC (n = 8/group).
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TABLE 2. Top 10 enriched gene sets (pathways) that are associated with aging and epicatechin supplementation in SkM




NABA_MATRISOME 1028 Ensemble of genes encoding
ECM and ECM-associated
proteins
137 0.1333 9.44E285 1.25E281
NABA_CORE_MATRISOME 275 Ensemble of genes encoding
core ECM, including ECM
glycoproteins, collagens,
and proteoglycans
68 0.2473 2.00E260 1.33E257
NABA_ECM_GLYCOPROTEINS 196 Genes encoding structural
ECM glycoproteins
42 0.2143 7.28E235 3.22E232
NABA_MATRISOME_
ASSOCIATED





69 0.0916 6.64E232 2.21E229
NABA_ECM_REGULATORS 238 Genes encoding enzymes and
their regulators involved in
the remodeling of the ECM
39 0.1639 8.52E228 2.26E225
KEGG_COMPLEMENT_AND_
COAGULATION_CASCADES
69 Complement and coagulation
cascades
25 0.3623 1.24E227 2.35E225
KEGG_PPAR_SIGNALING_
PATHWAY
69 PPAR-signaling pathway 25 0.3623 1.24E227 2.35E225
REACTOME_METABOLISM_OF_
LIPIDS_AND_LIPOPROTEINS
478 Genes involved in metabolism
of lipids and lipoproteins
51 0.1067 7.24E227 1.20E224
KEGG_FOCAL_ADHESION 201 Focal adhesion 35 0.1741 5.28E226 7.80E224
PID_INTEGRIN1_PATHWAY 66 Beta1-integrin cell surface
interactions




NABA_CORE_MATRISOME 275 Ensemble of genes encoding
core ECM, including ECM
glycoproteins, collagens,
and proteoglycans
20 0.0727 1.58E218 2.10E215
NABA_MATRISOME 1028 Ensemble of genes encoding
ECM and ECM-associated
proteins
29 0.0282 3.03E215 2.01E212
REACTOME_DEVELOPMENTAL_
BIOLOGY
396 Genes involved in
developmental biology
19 0.048 2.38E214 1.05E211
REACTOME_METABOLISM_OF_
LIPIDS_AND_LIPOPROTEINS
478 Genes involved in metabolism
of lipids and lipoproteins
20 0.0418 6.23E214 2.07E211
NABA_COLLAGENS 44 Genes encoding collagen
proteins
9 0.2045 3.47E213 8.96E211
PID_INTEGRIN1_PATHWAY 66 Beta1-integrin cell surface
interactions
10 0.1515 4.04E213 8.96E211
KEGG_PPAR_SIGNALING_
PATHWAY
69 PPAR-signaling pathway 10 0.1449 6.44E213 1.22E210
REACTOME_NEURONAL_
SYSTEM
279 Genes involved in neuronal
system
15 0.0538 2.75E212 4.44E210
REACTOME_TRANSMISSION_
ACROSS_CHEMICAL_SYNAPSES
186 Genes involved in transmission
across chemical synapses
13 0.0699 3.01E212 4.44E210
KEGG_ECM_RECEPTOR_
INTERACTION






NABA_CORE_MATRISOME 275 Ensemble of genes encoding
core ECM, including ECM
glycoproteins, collagens,
and proteoglycans
18 0.0655 1.14E222 1.52E219
NABA_MATRISOME 1028 Ensemble of genes encoding
ECM and ECM-associated
proteins
23 0.0224 2.51E218 1.67E215
PID_INTEGRIN1_PATHWAY 66 Beta1-integrin cell surface
interactions
10 0.1515 8.50E217 3.76E214
KEGG_ECM_RECEPTOR_
INTERACTION
84 ECM–receptor interaction 10 0.119 1.08E215 3.59E213
REACTOME_DEVELOPMENTAL_
BIOLOGY
396 Genes involved in
developmental biology
15 0.0379 1.76E215 4.68E213
NABA_COLLAGENS 44 Genes encoding collagen
proteins
8 0.1818 2.40E214 5.31E212
(continued on next page)
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matches the effect of epicatechin on serum NAD-related
molecule levels (Fig. 3). These results indicate that the
antiaging effect of epicatechin is likely mediated via these
4 pathways.
Epicatechin also reversed the age-related changes in
expression of select genes involved in fatty acid metabo-
lism (Table 2). The expression of Hacd2, or Ptplb, which
encodes the major 3-hydroxyacyl-CoA dehydratase in
SkM (23), was.1-fold lower in OCmice than in YCmice
but was normalized in ECmice (2.2, 0.98, and 2.4 FPKM),
respectively. Similarly, Fabp4, which is involved in cellular
fatty acid uptake, transport, and metabolism, exhibited
FPKM values of 732, 386, and 672 FPKM in YC, OC, and
EC; Acaca, encoding the enzyme responsible for the rate-
limiting step of fatty acid synthesis, had FPKM values of
7.3, 6.1, and 14.5 in YC, OC, and EC mice. Lastly, dietary
epicatechin treatmentmore than compensated for the age-
dependent declines in the expression of Slc1a3, encoding a
glutamate transporter, and Slc25a1, encoding a mito-
chondrial citrate transporter,with expressionvalues of 4.0,
2.4, and 5.5 FPKM, and 5.4, 3.8, and 12.4 FPKM in YC,OC,
and EC mice.
Myokines are important agents that regulate metabolic
responses and act as autocrine, endocrine, and/or para-
crine factors in SkM (24). Our analysis of gene expression
in SkM from old mice on the control diet compared with
EC old mice indicated 4 myokine-encoding genes with
statistically significant altered expression:Adipoq,Angptl4,
S100a8, and Sparc. Adipoq, Angptl4, and S100a8 increased
significantly in SkM from mice on EC supplementation
2.04-, 2.63-, and 9.39-fold, respectively (q = 0.0044 for all).
Levels of Sparc mRNA were noted to increase 1.42-fold
(q = 0.014) on the supplemented diet.
Epicatechin reverses age-associated changes
of protein expression in SkM
Todeterminewhether the alteredmRNA levels correlated
with their correspondingproteinexpression,wemeasured
several proteins whose transcripts were significantly
changedbyagingandwere reversedbyepicatechin inSkM.
Both actin mRNA and protein expression were reduced in
OC mice compared with YC mice, but epicatechin intake
significantly reversed both actin mRNA and protein ex-
pression (Fig. 5A, B). However, PPARg mRNA expression
was opposite to its protein expression in aged mice. As
shown in Fig. 5C, PPARg mRNA expression was signifi-
cantly reduced in OC mice compared with YC mice, but
PPARg protein expression was increased by 3-fold in the
OC group comparedwith the YC group (Fig. 5D), showing
that protein expression does not always correspond per-
fectly with its mRNA expression. Interestingly, epicatechin
intake reversed the age-altered PPARgmRNA and protein
expression in OC mice to levels similar to those in the YC
group, indicating that the response is maintained by epi-
catechin intake both in mRNA and protein levels.
DISCUSSION
There has been considerable interest in identifying natural
compounds that have the capacity to promote health and
extend life span. Polyphenolic compounds, including
resveratrol (25), green tea extract and its major bioactive
component EGCG (26), curcumin (27), and quercetin (28),
have been shown to extend life span in various model
organisms such as yeast, roundworms, fruit flies, and
obesemice. TheNational Institute on Aging Interventions
Testing Program, however, reported that the natural
compounds that presumably have potential to exert life-
extension effects, including resveratrol, green tea extract,
curcumin, oxaloacetic acid, and medium-chain triglycer-
ide oil, all failed to extend life span in standard diet–fed
leanmice (7). This outcome suggests that those previously
identified antiaging compounds exert an antiaging effect
only under certain pathologic conditions such as obesity
andmetabolic syndrome induced by long-term feeding of
a high-fat diet. In the present study, we present 4 lines of
evidence (survival rate, gene/and protein expression and
pathology in SkM, and serum metabolites) showing that
epicatechin supplementation exerts antiaging effects in
aged lean mice fed a standard diet. Hence, the present
study is important in antiaging research of natural com-
pounds because epicatechin exerted its antiaging effects in
normal aging mice without manipulation of their diet. In
line with improved health and prolonged life span, epi-
catechin intake improved aging-induced SkM degen-
eration and reversed aging-altered SkM mRNA and
protein expression of several key components of the ECM
and PPAR pathways, as well as the serum metabolomic
TABLE 2. (continued)
Gene Gene set name (pathway)a K Gene description k k/Kb P FDR q
KEGG_FOCAL_ADHESION 201 Focal adhesion 11 0.0547 2.31E213 4.22E211
REACTOME_COLLAGEN_
FORMATION
58 Genes involved in collagen
formation
8 0.1379 2.54E213 4.22E211
KEGG_PPAR_SIGNALING_
PATHWAY
69 PPAR-signaling pathway 8 0.1159 1.09E212 1.56E210
REACTOME_NCAM1_
INTERACTIONS
39 Genes involved in NCAM1
interactions
7 0.1795 1.17E212 1.56E210
FDR, false discovery rate; K, genes in gene set (n); k, genes shared (n); NCAM, neural cell adhesion molecule. aAssociated pathways with
differential gene expressions were identified by using Gene Set Enrichment Analysis (http://software.broadinstitute.org/gsea/msigdb). The list of top
100 pathways is provided in Supplemental Tables 2–4. bk/K = proportion of identified differential expression genes for a given gene set (pathway).
cTop 10 enriched pathways that were associated with aging in SkM. dTop 10 enriched pathways that were associated with epicatechin supple-
mentation in SkM of OC mice. eTop 10 enriched pathways that were associated with aging and epicatechin supplementation in SkM.
EPICATECHIN AND ANTI-AGING 973
profiles and the NAD pathway in old mice. Moreover,
EGCG, the major bioactive compound of green tea, did
not significantly increase the survival rate in agingmice in
this study (data not shown), indicating epicatechin is a
specialphytochemical eliciting antiaging effects. Together,
these findings suggest that epicatechinmaybeanovel food-
derived antiaging agent, acting in normal aging subjects at
least partially bydirectly exerting protective effects on SkM.
Progressive loss of SkM mass and muscle strength, a
condition known as sarcopenia, is one of the most notable
and debilitating alterations associated with the aging
process. Sarcopenia is noted in awide range of organisms,
fromnematodes, flies, rodents, andnonhumanprimates to
humans (29). This loss ofmusclemass and strength results
in the reduced capacity for endurance and increased
muscle wasting and fatigability, and therefore reduced
capacity for physical activity (30). In the present study, we
found that the effects of epicatechinareaccompaniedbyan
improvement in age-related decline of physical activity
and a reversal of age-induced SkM pathologic changes.
These data are supported by observations that epicatechin
reversed aging-associated changes in transcriptome pro-
files and protein expression of key elements of the ECM
andPPARpathways in SkM (Fig. 4). These results suggest
that dietary epicatechin may delay aging via maintaining
organ physiology and thereby normal function. Interest-
ingly, exercise (31), CR (32), or combined exercise and CR
(33) can attenuate age-induced SkM dysfunction, partic-
ularly through the PPAR-mediated suppression of in-
flammation. Therefore, epicatechin intake couldmimic the
antiaging and antisarcopenia effects of exercise and CR.
Myokines were examined for epicatechin-induced
changes in expression as an additional level of evidence
that the observed effects of diet supplementation act on
SkM in amanner that permits a broad range of effectswith
implications on muscle function. Four myokines showed
increased expression with epicatechin supplementation.
Adiponectin, encoded by Adipoq, has central metabolic
and insulin-sensitizing effects on SkM (34). Similarly,
Adipoq expression was increased in SkM of mice after
10 wk of endurance constant-moderate intensity exercise
with concomitant increase of expression of Ppargc1a and
Ucp2 (35). Several roles have been ascribed to Angptl4,
including triglyceride trafficking intoperipheral tissues for
use as fuel (36), notably in active SkM(24), andaprotective
role against muscle atrophy (37). Expression of myokine
S100a8 increased inmuscle after exercise (38) and in fasting
statehumanbloodwas correlatedwith lactate levels at rest
(39). Human SPARCwas up-regulated in SkM after exer-
cise training regardless of age or type of exercise, with an
assigned role in angiogenesis (40). For these 4 myokines,
the epicatechin-stimulated increases in expression mirror
expression values observed in YC samples.
Data from a serum metabolomic analysis showed that
dietary supplementation of epicatechin significantly shif-
ted the metabolic profiles of old mice toward those
in young mice (Fig. 3A). Notably, epicatechin restored
the down-regulated NAD metabolic pathway, which
could primarily mediate the epicatechin antiaging effect
(Table 1). NAD+ is an essential electron transporter in
mitochondrial respiration and oxidative phosphorylation.
It was found that NAD+ levels decline with age due to
increased NAD+ catabolism in rodent and human tissues
(19), and maintaining NAD+ levels could reverse age-
related multiple disorders in old mice (20). We observed
that circulating levels of 2 NAD metabolites (nicotinate
Figure 5. Dietary epicatechin
reversed age-associated protein
expressions in SkM of aged
mice. Skeletal muscle samples
(quadriceps) were collected at
37 wk in the EC and OC groups
or at 12 mo of age in the YC
group (n = 12/group). Total
actin (all 6 isoforms) (B) or
PPARg (D) protein expression
was measured by Western blot
and normalized to glyceralde-
hyde-3-phosphate dehydroge-
nase (GAPDH) content. The
mRNA expression of actin (A)
or PPARg (C) was obtained
from the RNA sequencing as
described in Fig. 4. #P , 0.05
EC vs. YC, *P , 0.05 EC vs.
(n = 8/group).
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ribonucleoside and nicotinamide) were significantly re-
duced in old mice but were restored by epicatechin (Fig.
3E, F).Consistently, 5NAD-relatedgene transcripts (Nadk,
Nadsyn1,Nnmt,Nt5c2, andQprt) declined during aging in
SkMbutwere reversedby treatmentwith epicatechin (Fig.
4E). These results corroborate a study that dietary cocoa
polyphenol augmented intracellular NAD+ pools in di-
abetic rats (41). Collectively, these facts suggest that the
epicatechin antiaging effect may be at least partially me-
diated by NADmetabolism.
The SkM ECM, a collection of extracellular molecules
secreted by cells that accounts for;10%ofmuscleweight,
is vital in tissuedevelopment, structural support, and force
transmission. The major molecules of ECM in SkM are: 1)
type I, III, and VI collagens and fibronectin located in the
outer reticular lamina; and 2) collagen type IVand laminin
located in the inner basal lamina (42). Structural and bi-
ologic changes, including increased collagen levels and
decreased collagen turnover with accumulation of enzy-
matically mediated collagen cross-links, contribute to the
deterioration in muscle mechanical properties with aging
(43). It has been reported that ECM mediates the SkM
aging process in seals (44), mice (21), and rats (45) by dis-
ruptingmuscle stemcell function (46). In thepresent study,
ECM-related gene sets dominate the top aging-sensitive
gene sets (4 of 10 top gene sets) comparing youngmice, old
mice, and old mice treated with epicatechin. Most impor-
tantly, 24 genes (including type I, III, IV and VI collagens,
laminin, and fibrillin) of theMatrisome gene set (ensemble
of 1028 genes encoding ECM and ECM-associated pro-
teins) were reduced in aged mice but were significantly
reversed by epicatechin intake, confirming that epicatechin
has the ability to reverse an important aspect of SkMaging.
Thus, the epicatechin antiaging effects at least can be me-
diated by altered ECM in the aging SkM.
We found that PPAR, the nuclear hormone receptor
superfamily of transcription factors, is the second top
molecule contributing to the epicatechin-induced changes
of SkM gene expression. The transcription of 9 genes was
significantly reduced in old mice compared with young
mice, butEC intakesignificantly reversed theexpressionof
all 9genes (Fig. 3A), indicating that this signalingpathway,
particularly PPARg, may mediate the protective effect of
EC in SkM. In fact, PPARg is expressed in a range of tis-
sues, including adipocytes, SkM cells, osteoclasts, and
others, which itself suggests that dietary EC also affects
other tissues. PPARg plays a vital role in a broad spectrum
of biologic processes (47), and it is an important anti-
inflammatory factor (48). It has been shown that in-
flammation is a major cause of sarcopenia (22). Aging
is associated with increased low-grade, chronic inflam-
mation accompanied by reduced PPARg activity and
expression (32), whereas exercise (31), CR (32), and com-
bined exercise and CR (33) can reverse the alterations
of PPARg and inflammation, thereby attenuating age-
induced SkM dysfunction. Our results indicate that EC
intake might mimic the effects of exercise and CR on the
anti-inflammation and PPARg by reversing age-altered
PPARg protein and gene expressions in SkM (Fig. 5C, D).
Moreover, we found that the mRNA levels of Nfkb2,
encoding NFkB, was significantly increased in SkM of old
mice compared with that in young mice. However, EC
almost completely reversed the abnormally increased ex-
pression of Nfkb2 in SkM of old mice. Because the anti-
inflammatory effect of PPARg is mediated via inhibiting
NF-kB transcriptional activity in SkM (49), the effect of EC
on Nfkb2 might be secondary, and thereby EC up-
regulated PPARg. Nevertheless, the antiaging effects of
EC may be partially due to its anti-inflammatory action
mediated by PPARg.
In support of the epicatechin-directed gene expression
changes in components of the PPARg-signaling pathway
and its role in fatty acid metabolism, we observed 3 genes
involved in this metabolic process (Acaca, Fabp4, and
Hacd2) whose expression in SkM of old mice was signifi-
cantly changedcomparedwith that in the SkMofYCmice.
These expression changes also completely reversed the
observed age-related declines in mRNA counts. Because
increased accumulation of lipid content in aging SkM
couldcauseprogressivesarcopenia (30), themRNAprofile
of these genes as induced by dietary epicatechin is note-
worthy. In addition, epicatechin-reversed expression of
the high-affinity glutamate transporter Slc1a3, or EAAT1,
was shown to promote resistance to hypoxic injury in
astrocyte-neuron cocultures (50); this finding may be rel-
evant to cellular processes of the neuromuscular junction
(51) and hence overall SkM function.
There are several limitations of the present study. First,
the mice were euthanized when the control group had
12 mice left; a complete Kaplan-Meier survival curve is
needed for this antiaging study. Second, only a single dose
of pure epicatechin (0.25% w/v) was used; this dosage is
very high and very difficult to achieve by dietary intake of
foods containing epicatechin. Thus, a dose-dependent
study is needed to assess whether a lower dosage has
similar effects. Third, it is unclear from this studywhether
EC has a similar life span– extending effect in femalemice,
as sex couldplay an important role in agingdynamics (52).
Naturally, this epicatechin antiaging effect alsomay result
from the impact on other organs such as the brain, liver,
heart, and spleen.
In summary, to the best of our knowledge, we have
shown for the first time that the dietary intake of epi-
catechin significantly increased the survival rate of aged
normal mice fed a standard diet. This antiaging effect of
epicatechin is associated with improvements in physical
activity and changes in serum metabolite and SkM tran-
scription profiles toward those of YC mice. Particularly,
epicatechin intake abrogated the age-induced down-
regulation of the NAD pathway both in serum and SkM
aswell as in ECMandPPARpathways in SkM.Given that
epicatechin exerts these effects in aging mice without
modulation of their diet, it could be a potential food-
derived small molecule capable of prolonging a healthy
life span.
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